Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07430007 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exercise and Dietary Lifestyle Intervention on Reducing Atrial Fibrillation Burden, Cardiac and Body Fat Mass.

Study acronym: MOVE-AF
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is strongly associated with obesity and excess body fat. Lifestyle interventions, including exercise and dietary modification, may reduce AF burden, but long-term randomized controlled trial evidence with objective AF burden assessment and advanced cardiac imaging is limited. The MOVE-AF trial is a randomized controlled trial designed to evaluate whether a 12-month tailored exercise and dietary lifestyle intervention, compared with usual care, reduces atrial fibrillation burden and symptom severity and decreases cardiac and total body fat mass in overweight and obese adults with paroxysmal or persistent AF.
Trial Details
NCT Number NCT07430007
Lead Sponsor University of Eastern Finland
Collaborators: Kuopio University Hospital, Tampere University Hospital, UKK Institute, Hospital Nova, Central Finland
Conditions
(from sponsor)		 Atrial Fibrillation (AF), Obesity & Overweight
Related terms Atrial Fibrillation, Obesity, Overweight
Enrollment 158 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov